NCT00721201View on ClinicalTrials.gov

Glucocorticoid Receptor Antagonism in Subclinical Cushings

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Subclinical Cushing's
Interventions
DRUG

Mifepristone

Use of mifepristone 200mg bd for 8 weeks

Trial Locations (1)

Unknown

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

Sponsors

Collaborators (1)

HRA Pharma
All Listed Sponsors
collaborator

HRA Pharma

INDUSTRY

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT00721201 - Glucocorticoid Receptor Antagonism in Subclinical Cushings | Biotech Hunter | Biotech Hunter